Scientific program

Thursday, 16.05.2024

  • 09.00 Registration
  • 10.00 – 13.00 Paralell workshops
  • Workshop no. 1: 
    Functional anatomy and US guidance in cervical dystonia (hands on)
  • - Agnieszka Przystańska (Poznań, Łódź, Poland)
    - Artur Drużdż (Poznań, Łódź, Poland)
    - Małgorzata Tyślerowicz (Poznań, Łódź, Poland)
  • Trainers:
    Artur Drużdż, Michał Schinwelski, Małgorzta Tyślerowicz, Justyna Gawryluk
    (4 US stands, 5 participants maximum, total: 20 participants)
  • Workshop no. 2: 
    Botulinum toxin in the treatment of chronic migraine and other pain syndromes (hands on, patient presentations)
  • - Magdalena Boczarska-Jedynak (Oświęcim, Poland)
    - Lars Bendtsen (Copenhagen, Denmark)
    - Marta Waliszewska-Prosół (Wrocław, Poland)
  • Workshop no. 3: 
    Spasticity in adults – examination, decision options, muscle selection and patient injections (hands on, patients)
  • - Iwona Sarzyńska-Długosz (Warszawa, Poland)
    - Jorge Jacinto (Lisbon, Portugal)
  • 13.00 – 14.00 Lunch break
  • 14.00 – 14.10 Opening remarks - Jarosław Sławek
  • 14.10 – 14.50 Opening lecture: 
    Musician’s cramps – what did they teach us on dystonia pathophysiology?
    - Eckart Altenmüller (Hannover, Germany)
  • 14.50 - 15.00 Q&A
  • 15.00 – 16.45 Session no. 1: Cervical dystonia
    Moderators: Anna Castagna (Milano, Italy), Jarosław Sławek (Gdańsk, Poland)
  • 15.00 - 15.25 COL- CAP concept and modern approach to the pattern and muscle selection (based on case studies)
    - Wolfgang Jost (Freiburg, Germany)
  • 15.25 - 15.50 How to optimize the effect of the treatment of cervical dystonia? (complex pharmacological and physiotherapy approach)
    - Anna Castagna (Milano, Italy)
  • 15.50 - 16.10 Non-motor aspects of cervical dystonia and other barriers in the treatment
    - Jarosław Sławek (Gdańsk, Poland)
  • 16.10 - 16.30 Navigating injections (US, EMG) – is it helpful?
    - Małgorzata Tyślerowicz (Łódź, Poland)
  • 16.30 - 16.45 Q&A
  • 16.45 - 17.15 Coffee break 
  • 17.15 - 18.30 Session no. 2: Botulinum Neurotoxin in other movement disorders (part 1)
    Moderators: Wojciech Duzynski (Malmoe, Sweden), Michał Schinwelski (Gdańsk, Poland)
  • 17.15 - 17.35 Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal
    - Wolfgang Jost (Freiburg, Germany)
  • 17.35 - 17.55 Tremors – to treat or not to treat?
    - Monika Rudzińska (Kraków, Poland)
  • 17.55 - 18.15 Siallorhea – common and disabling complication of various movement disorders
    - Jarosław Sławek (Gdańsk, Poland)
  • 18.15 - 18.30 Q&A
  • 18.30 – 18.45 Coffee break 
  • 18.45 – 19.30 Sesion no. 3: „Show me your case” – video session on decision making in dystonia
    Moderators: Monika Rudzińska (Kraków, Poland), Wolfgang Jost (Freiburg, Germany)
  • 18.45 - 19.15 3 participants – 10 min presentations
  • 19.15 - 19.30 Q&A
  • 20.00 - 22.00 Dinner

Friday, 17.05.2024

  • 09.00 – 11.00 Paralell workshops
  • Workshop no. 4: 
    Cervical dystonia – clinical assessment, potential pitfalls and case studies (US guided injections of patients)
  • - Anna Castagna (Milano, Italy) 
    - Jarosław Sławek (Gdańsk, Poland)
  • Workshop no. 5: 
    Functional anatomy and US guidance in spasticity of the arm and forearm (hands on)
  • - Agnieszka Przystańska (Poznań, Poland)
    - Artur Drużdż (Poznań, Poland)
    - Michał Schinwelski Gdańsk, Poland)
  • Trainers:
    Artur Drużdż, Michał Schinwelski, Małgorzata Dec-Ćwiek, Iwona Sarzyńska-Długosz
  • Workshop no. 6: 
    Update on Bo-NT use in children upper and lower limb spasticity (case studies)
  • - Marcin Bonikowski (Warszawa, Poland)
    - Weronika Pyrzanowska (Warszawa, Poland)
  • 11.00 – 11.30 Coffee break 
  • 11.30 - 12.30 Meet the expert (parallel)
  • A practical guide to botulinum neurotoxin treatment of shoulder spasticity: anatomy, physiology, goal setting and injection technique
    - Jorge Jacinto (Lisbon, Portugal)
  • A practical guide to the treatment of trigeminal neuralgia
    - Lars Bendtsen (Copenhagen, Denmark)
  • 12.30 - 13.30 Lunch break 
  • 13.30 - 14.45 Session no. 4: Botulinum toxin in pain syndromes
    Moderators: Marta Waliszewska-Prosół (Wrocław, Poland), Magdalena Boczarska-Jedynak (Oświęcim, Poland)
  • 13.30 -13.50 Update on the treatment of chronic migraine
    Lars Bendtsen (Copenhagen, Denmark)
  • 13.50 - 14.10 Injection technique of the upper face with onabotulinumtoxinA in chronic migraine: a critical appraisal
    - Magdalena Boczarska-Jedynak (Oświęcim, Poland)
  • 14.10 - 14.30 Bo-NT in other pain syndromes – review
    - Marta Waliszewska-Prosół (Wrocław, Poland)
  • 14.30 -14.45 Q&A
  • 14.45 - 16.45 Session no. 5: Spasticity in adults and children
    Moderators: Jorge Jacinto (Lisbon, Portugal), Iwona Sarzyńska-Długosz (Warszawa, Poland)
  •  14.45 - 15.10 Assessement of spastic patient and clinical decision making 
    - Serdar Kocer (Porrentruy, Switzerland)
  • 15.10 - 15.35 A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus
    - Jorge Jacinto (Portugal)
  • 15.35 - 16.00 Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity
    - Michał Schinwelski (Gdańsk, Poland)
  • 16.00 - 16.25 Spasticity in cerebral palsy – long term efficacy and treatment paradigms
    - Marcin Bonikowski (Warszawa, Poland)
  • 16.25 - 16.45 Q&A
  • 16.45 – 17.15 Coffee break 
  • 17.15 -18.15 Session no. 6: „Show me your case”– video session on decision making in spasticity
    Moderators: Małgorzata Dec-Ćwiek (Kraków, Poland), Serdar Kocer (Porrentruy, Switzerland)
  • 17.15 - 18.00 3 cases presented by participants - each 15 min presentation
  • 18.00 - 18.15 Q&A
  • 18.15 - 20.15 Workshop no. 7 (repeated): Functional anatomy and US guidance in spasticity of the arm and forearm (hands on)
  • - Agnieszka Przystańska (Poznań, Poland)
    - Artur Drużdż (Poznań, Poland)
    - Michał Schinwelski Gdańsk, Poland)
  • Trainers (at US stand):
    Artur Drużdż, Michał Schinwelski, Małgorzata Dec-Ćwiek, Justyna Gawryluk
  • 20.00 Dinner

Saturday, 18.05.2024

  • 9.00- 10.30 Session nr 7 Botulinum Neurotoxin for different indications
    Moderators: Monika Rudzińska (Kraków, Poland), Jarosław Sławek (Gdańsk, Poland)
  • 09.00 - 09.20 Hemifacial spasm - current therapeutic approaches      
    - Wojciech Dużynski (Malmoe, Sweden)
  • 09.20 - 09.40 Bruxism, Meige’s syndrome and other facial spasms
    - Justyna Gawryluk (Katowice, Poland)
  • 09.40 - 10.00 Hyperhydrosis
    - Przemysław Nowak, (Jarosław, Poland)
  • 10.00 - 10.20 Emerging indications and future directions
    - Monika Rudzińska (Kraków, Poland)
  • 10.20 - 10.30 Q&A
  • 10.30 - 10.45 Coffee break
  • 10.45 – 11.15 Meet the Expert (parallel)
  • Decision making in dystonia: from pharmacological treatment to surgical therapies
    - Jarosław Sławek (Gdańsk, Poland)
  • Decision making in spasticity: Bo-NT and intrathecal baclofen
    - Iwona Sarzyńska- Długosz (Warszawa, Poland)
  • 11.15 - 11.30 Closing remarks – Jarosław Sławek
  • 11.30 – 14.00 Paralell workshops
  • Workshop no. 8: Functional anatomy, clinical examination and US guidance in spasticity of the lower limb (hands on)
  • - Agnieszka Przystańska (Poznań, Poland)
    - Artur Drużdż (Poznań, Poland)
    Marcin Bonikowski (Warszawa, Poland)
  • Trainers (one US stand):
    Artur Drużdż, Marcin Bonikowski, Michał Schinwelski, Justyna Gawryluk
  • Workshop no. 9: Upper limb spasticity in different indications (hands on, patient’s injections)
  • - Serdar Kocer (Porrentruy, Switzerland)
    - Iwona Sarzyńska-Długosz (Warszawa, Poland)

 

The organizer reserves the right to change the conference program.
The conference is addressed to persons authorized to issue prescriptions or persons trading in medicinal products - legal basis: Pharmaceutical Law Act of September 6, 2001 (Journal of Laws of 2008 No. 45, item 271).

 

Organizator zastrzega sobie prawo zmian w programie konferencji.
Konferencja jest skierowany do osób uprawnionych do wystawiania recept lub osób prowadzących obrót produktami leczniczymi — podstawa prawna: Ustawa z dnia 6 września 2001 r. Prawo farmaceutyczne (Dz.U. z 2008 r. nr 45, poz. 271).